EGFR Positive UK
Home News Contact
Donate
Our Mission Our Early Diagnosis Campaigns Real Life Stories Who We Are 5 Years of EGFR+ UK! Inclusion and Diversity Our Policies Annual Report 2024/25
What is EGFR? Treatment Options Glossary
EGFR Good Practice Guide Crisis support Videos Mental Wellbeing Support Clinical Trials Travelling with Lung Cancer Other Resources
Donating Fundraising
Home About Us Our Mission Our Early Diagnosis Campaigns Real Life Stories Who We Are 5 Years of EGFR+ UK! Inclusion and Diversity Our Policies Annual Report 2024/25 About EGFR What is EGFR? Treatment Options Glossary Patient Support EGFR Good Practice Guide Crisis support Videos Mental Wellbeing Support Clinical Trials Travelling with Lung Cancer Other Resources NewsContact Get Involved Donating Fundraising
EGFR Positive UK
Offering hope & learning for those with EGFR+
Donate
 

News

 
news-purple.jpg
UKLCC Covid Matters Report
UKLCC Covid Matters Report
EGFR PositiveOctober 31, 2020
Osimertinib approved for untreated EGFR mutation-positive NSCLC
Osimertinib approved for untreated EGFR mutation-positive NSCLC
EGFR PositiveOctober 14, 2020
Osimertinib approved for treating EGFR mutation positive NSCLC
Osimertinib approved for treating EGFR mutation positive NSCLC
EGFR PositiveOctober 14, 2020
Adjuvant Osimertinib in Early-Stage EGFR-Positive NSCLC
Adjuvant Osimertinib in Early-Stage EGFR-Positive NSCLC
Guest UserJune 10, 2020
UKLCC Early Diagnosis Matters Report
UKLCC Early Diagnosis Matters Report
EGFR PositiveFebruary 4, 2020
Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
EGFR PositiveNovember 25, 2019
EGFR Positive UK first meeting
EGFR Positive UK first meeting
Guest UserNovember 16, 2019
Newer

The latest news

News
EGFR+ Lung Cancer UK Member Conferences 2026–2027
October 13, 2026
EGFR+ Lung Cancer UK Member Conferences 2026–2027
October 13, 2026
Read more →
October 13, 2026
Our Lungs: Time to Breathe premieres in London
September 10, 2026
Our Lungs: Time to Breathe premieres in London
September 10, 2026
Read more →
September 10, 2026
Our 2026 Members' Experience Survey Is Now Open
July 30, 2026
Our 2026 Members' Experience Survey Is Now Open
July 30, 2026
Read more →
July 30, 2026
Step Up for EGFR+ Lung Cancer UK this August
July 16, 2026
Step Up for EGFR+ Lung Cancer UK this August
July 16, 2026
Read more →
July 16, 2026
EGFR+ UK publishes first position statement on adjuvant osimertinib follow-up care
June 17, 2026
EGFR+ UK publishes first position statement on adjuvant osimertinib follow-up care
June 17, 2026
Read more →
June 17, 2026
Breathe Strong Season 1: It's A Wrap!
April 29, 2026
Breathe Strong Season 1: It's A Wrap!
April 29, 2026
Read more →
April 29, 2026

EGFR+ UK are proud members of Lung Cancer Europe

 
 
 
 
View fullsize Cardiff registration is now open 💚 Join us in Cardiff for our EGFR+ Lung Cancer UK Member Conference. 📍 Principality Stadium, Cardiff 📅 Wednesday 18 November 2026 🕙 10:00–16:00 👥 In person This free one-day event is for people in the UK
View fullsize How do scientists go from millions of possible molecules to a new treatment for EGFR+ lung cancer? Our latest Ask the Expert session is now available to watch, and it’s a fascinating look behind the scenes of drug discovery. Geoff Holdgate, f
View fullsize Promising results for uncommon EGFR+ lung cancer. New research published in Cancer Cell has reported encouraging results for firmonertinib, an experimental targeted treatment for people with EGFR PACC mutations. What are PACC mutations? They&rsquo
View fullsize
View fullsize Glasgow registration is now open 💚 Join us for the first EGFR+ Lung Cancer UK Member Conference of the 2026–2027 series. 📍 The Studio, 67 Hope Street, Glasgow G2 6AE 📅 Wednesday 4 November 2026 🕙 10:00–16:00 💻 Hybrid: attend in per
View fullsize Last few days to have your say! The Lung Cancer Europe survey closes this Wednesday. As a member of @lungcancereurope, EGFR+ Lung Cancer UK is supporting its 12th Annual Report Survey, which is now in its final few days. This year, the survey is lo

Medical Disclaimer

The contents of this website are for informational purposes. The content is NOT a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified professional with any question you have regarding a medical condition. EGFR Positive UK does not endorse any companies, products or opinions that may be mentioned on this website.


© 2026 EGFR POSITIVE UK - Charity nº 1189722


PRIVACY POLICY

COOKIE POLICY